Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy, Pruritus, Pseudolymphoma, Skin mass
Clinical narrative: Itchy area on forehead/ Itchy lesion on stomach not dense and smaller; but she thinks it is another pseudolymphoma; Kidney sized bump on the stomach; Bump was diagnosed as pseudolymphoma/ Bump or pimple on forehead; This spontaneous case was reported by a consumer and describes the occurrence of SKIN MASS (Kidney sized bump on the stomach), PSEUDOLYMPHOMA (Bump was diagnosed as pseudolymphoma/ Bump or pimple on forehead), PRURITUS (Itchy area on forehead/ Itchy lesion on stomach not dense and smaller) and PSEUDOLYMPHOMA (but she thinks it is another pseudolymphoma) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported.  On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-May-2021, the patient experienced PSEUDOLYMPHOMA (Bump was diagnosed as pseudolymphoma/ Bump or pimple on forehead). On 01-Oct-2021, the patient experienced SKIN MASS (Kidney sized bump on the stomach) and PSEUDOLYMPHOMA (but she thinks it is another pseudolymphoma). On 22-Nov-2021, the patient experienced PRURITUS (Itchy area on forehead/ Itchy lesion on stomach not dense and smaller). At the time of the report, SKIN MASS (Kidney sized bump on the stomach) was resolving, PSEUDOLYMPHOMA (Bump was diagnosed as pseudolymphoma/ Bump or pimple on forehead) had resolved, PRURITUS (Itchy area on forehead/ Itchy lesion on stomach not dense and smaller) had not resolved and PSEUDOLYMPHOMA (but she thinks it is another pseudolymphoma) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available):In June 2021, Biopsy: abnormal (abnormal) In Jul-2021 results revealed pseudolymphoma.No concomitant medications were reported.On 01-May-2021, three and half weeks after receiving second dose, the patient had pimple or bump on the forehead which was later diagnosed as pseudolymphoma on an unknown date in Jul-2021.On an unknown date in Aug-2021, the patient started treatment with steroid cream  and the bump went away but left a dent on the forehead. On 01Oct 2021, she reported another kidney sized bump on her stomach.  She stated it itched and looked like lymphoma,  but she thought it was another psuedolymphoma. On 22-Nov-2021, the lesion was itchy, not as dense and was smaller. The bump had shrunk. Patient had another appointment for biopsy.It was reported that the vaccine efficacy was probably waning and patient did not take booster dose yet.Company comment-This spontaneous case concerns a 59-year-old female patient with no relevant medical history, who experienced the unexpected non serious events of Pseudo lymphoma, Skin mass and pruritus. The event of Pseudolymphoma occurred approximately 3.5 weeks after the second dose of mRNA- 1273 vaccine and the event skin mass and pruritus happened approximately after 9 weeks after the second dose of the mRNA 1273 vaccine . Clinical manifestations included a pruriginous mass in the forehead. Skin biopsy showed pseudolymphoma. She was prescribed a topical steroid cream,  with resolution of the skin bump. The event Skin mass  with clinical manifestations included a "kidney sized" skin mass on her stomach associated with pruritus. Skin biopsy is pending. The rechallenge is not applicable, since the events were reported exclusively after the second dose. The benefit-risk relationship of mRNA- 1273 vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 59-year-old female patient with no relevant medical history, who experienced the unexpected non serious events of Pseudo lymphoma, Skin mass and pruritus. The event of Pseudolymphoma occurred approximately 3.5 weeks after the second dose of mRNA- 1273 vaccine and the event skin mass and pruritus happened approximately after 9 weeks after the second dose of the mRNA 1273 vaccine . Clinical manifestations included a pruriginous mass in the forehead. Skin biopsy showed pseudolymphoma. She was prescribed a topical steroid cream,  with resolution of the skin bump. The event Skin mass  with clinical manifestations included a "kidney sized" skin mass on her stomach associated with pruritus. Skin biopsy is pending. The rechallenge is not applicable, since the events were reported exclusively after the second dose. The benefit-risk relationship of mRNA- 1273 vaccine is not affected by this report.